Legato Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,395
| Closed | -$277K | – | 582 |
|
|
2024
Q4 | $277K | Sell |
10,395
-15,890
| -60% | -$423K | 0.04% | 506 |
|
|
2024
Q3 | $750K | Buy |
26,285
+12,130
| +86% | +$346K | 0.09% | 368 |
|
|
2024
Q2 | $308K | Buy |
+14,155
| New | +$308K | 0.04% | 487 |
|
|
2023
Q2 | – | Sell |
-27,534
| Closed | -$626K | – | 585 |
|
|
2023
Q1 | $626K | Buy |
27,534
+9,038
| +49% | +$205K | 0.11% | 311 |
|
|
2022
Q4 | $435K | Buy |
+18,496
| New | +$435K | 0.08% | 374 |
|